C-Terminal Modifications of Histidyl-N-benzylglycinamides To Give Improved Inhibition of Ras Farnesyltransferase, Cellular Activity, and Anticancer Activity in Mice
- 1 October 1997
- journal article
- letter
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 40 (21) , 3319-3322
- https://doi.org/10.1021/jm970470c
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Antitumor 8-chlorobenzocycloheptapyridines: a new class of selective, nonpeptidic, nonsulfhydryl inhibitors of ras farnesylationBioorganic & Medicinal Chemistry, 1997
- PROTEIN PRENYLATION: Molecular Mechanisms and Functional ConsequencesAnnual Review of Biochemistry, 1996
- Development of Highly Potent Inhibitors of Ras Farnesyltransferase Possessing Cellular andin VivoActivityJournal of Medicinal Chemistry, 1996
- ras GENESAnnual Review of Biochemistry, 1987
- Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro.Proceedings of the National Academy of Sciences, 1975
- Synthesis of the Carboxyl-Terminal Heptapeptide Sequence of Bovine Pancreatic RibonucleaseJournal of the American Chemical Society, 1966